We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$32.9B
AUM Growth
-$855M
Cap. Flow
-$1.68B
Cap. Flow %
-5.1%
Top 10 Hldgs %
29.62%
Holding
1,163
New
73
Increased
397
Reduced
461
Closed
98

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$87.5M
2
SHW icon
Sherwin-Williams
SHW
+$76.1M
3
HD icon
Home Depot
HD
+$68M
4
LIN icon
Linde
LIN
+$55M
5
BMY icon
Bristol-Myers Squibb
BMY
+$50.3M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$95.3M
2
AAPL icon
Apple
AAPL
+$83.2M
3
AVGO icon
Broadcom
AVGO
+$76.2M
4
ELV icon
Elevance Health
ELV
+$71.4M
5
NVDA icon
NVIDIA
NVDA
+$69.2M

Sector Composition

Rank Sector Weight
1 Technology 37.44%
2 Healthcare 14.27%
3 Consumer Discretionary 12.23%
4 Financials 8.85%
5 Industrials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
J icon
351
Jacobs Solutions
J
$17B
$12.2M 0.04%
92,092
+55,014
+148% +$7.57M
THC icon
352
Tenet Healthcare
THC
$21B
$12M 0.04%
94,700
+27,998
+42% +$4.16M
BEPC icon
353
Brookfield Renewable
BEPC
$5.39B
$12M 0.04%
432,151
-251,179
-37% -$7.72M
AZO icon
354
AutoZone
AZO
$46.7B
$11.9M 0.04%
3,717
-389
-9% -$1.23M
APA icon
355
APA Corp
APA
$16.6B
$11.9M 0.04%
514,969
+269,447
+110% +$6.3M
ANF icon
356
Abercrombie & Fitch
ANF
$5.74B
$11.9M 0.04%
79,350
+7,146
+10% +$1.04M
ETR icon
357
Entergy
ETR
$49.2B
$11.9M 0.04%
156,294
+83,838
+116% +$6.05M
CB icon
358
Chubb
CB
$132B
$11.7M 0.04%
42,468
-17,005
-29% -$4.83M
OMC icon
359
Omnicom Group
OMC
$21.9B
$11.7M 0.04%
135,954
+7,310
+6% +$725K
EIX icon
360
Edison International
EIX
$21B
$11.1M 0.03%
139,116
-32,103
-19% -$2.68M
TTC icon
361
Toro Company
TTC
$8.81B
$11M 0.03%
137,861
+245
+0.2% +$20.5K
OHI icon
362
Omega Healthcare
OHI
$14.3B
$10.9M 0.03%
287,770
+40,706
+16% +$1.63M
BNTX icon
363
BioNTech
BNTX
$24.3B
$10.7M 0.03%
94,150
-149
-0.2% -$17K
CSX icon
364
CSX Corp
CSX
$90.1B
$10.7M 0.03%
330,519
-325,878
-50% -$11.2M
OKE icon
365
Oneok
OKE
$59.7B
$10.5M 0.03%
104,610
-57,831
-36% -$5.92M
GAP
366
The Gap Inc
GAP
$7.18B
$10.5M 0.03%
442,398
+247,152
+127% +$5.63M
LYB icon
367
LyondellBasell Industries
LYB
$21.1B
$10.4M 0.03%
140,450
+41,998
+43% +$3.53M
VERA icon
368
Vera Therapeutics
VERA
$2.43B
$10.4M 0.03%
245,879
-390
-0.2% -$17.3K
VRE
369
DELISTED
Veris Residential
VRE
$10.2M 0.03%
613,908
+64,772
+12% +$1.13M
SON icon
370
Sonoco
SON
$4.77B
$10.1M 0.03%
+206,921
New +$10.7M
EWBC icon
371
East-West Bancorp
EWBC
$17.6B
$10.1M 0.03%
105,317
+1,701
+2% +$167K
MBLY icon
372
Mobileye
MBLY
$6.73B
$9.98M 0.03%
501,069
-11,478
-2% -$181K
WK icon
373
Workiva
WK
$4.07B
$9.97M 0.03%
91,045
-2,805
-3% -$259K
JD icon
374
JD.com
JD
$36.6B
$9.92M 0.03%
285,988
+61,020
+27% +$2.36M
CSL icon
375
Carlisle Companies
CSL
$12.9B
$9.85M 0.03%
26,701
-5,501
-17% -$2.4M

Similar funds

Axa's Q4 2024 Portfolio in Review

As of Q4 2024, Axa held 1,163 positions worth $32.9B, down 2.5% from $33.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Axa withdrew a net $1.68B in Q4 2024, closing 98 positions and reducing 461 holdings. Its most notable exit was Altair Engineering Inc, an estimated $67.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in JBT Marel worth $34.4M.

  • Axa's largest Q4 2024 buy was JBT Marel: 270,829 shares worth $34.4M.
  • Axa added most to Salesforce in Q4 2024, an estimated $87.5M increase.
  • Axa's biggest Q4 2024 reduction was Advanced Micro Devices, cutting an estimated $95.3M.
  • Axa fully exited Altair Engineering Inc in Q4 2024, selling an estimated $67.5M.
  • Axa's ten largest holdings make up 30% of its $32.9B portfolio in Q4 2024.
  • Axa opened 73 new positions and closed 98 in Q4 2024.
  • Axa's portfolio value fell 2.5% quarter-over-quarter to $32.9B.

Based on Axa's 13F filing for Q4 2024, filed 14 Feb 2025.